HUM vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Mar 31, 2026

HUM

62.2
AI Score
VS
HUM Wins

CLOV

50.0
AI Score

Investment Advisor Scores

HUM

62score
Recommendation
BUY

CLOV

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HUM CLOV Winner
Forward P/E 18.7617 81.9672 HUM
PEG Ratio 0.9922 0 Tie
Revenue Growth 11.3% 44.7% CLOV
Earnings Growth -59.3% 0.0% CLOV
Tradestie Score 62.2/100 50.0/100 HUM
Profit Margin 0.9% -4.5% HUM
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD HUM

Frequently Asked Questions

Based on our detailed analysis, HUM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.